Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103402112 | 10340211 | 2 | F | 20160714 | 20140724 | 20160715 | EXP | PT-BRISTOL-MYERS SQUIBB COMPANY-21217096 | BRISTOL MYERS SQUIBB | 74.00 | YR | M | Y | 0.00000 | 20160715 | OT | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103402112 | 10340211 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
| 103402112 | 10340211 | 2 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 3 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 5 | C | CILAZAPRIL | CILAZAPRIL ANHYDROUS | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 7 | C | EUFILINA | 2 | Unknown | U | 0 | |||||||||||
| 103402112 | 10340211 | 8 | C | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 9 | C | EPINITRIL | NITROGLYCERIN | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 11 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 103402112 | 10340211 | 12 | C | CHRONIC OXYGEN THERAPY | 2 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103402112 | 10340211 | 1 | Chronic kidney disease |
| 103402112 | 10340211 | 2 | Lung infection |
| 103402112 | 10340211 | 3 | Lung infection |
| 103402112 | 10340211 | 4 | Product used for unknown indication |
| 103402112 | 10340211 | 5 | Product used for unknown indication |
| 103402112 | 10340211 | 6 | Product used for unknown indication |
| 103402112 | 10340211 | 7 | Product used for unknown indication |
| 103402112 | 10340211 | 8 | Product used for unknown indication |
| 103402112 | 10340211 | 9 | Product used for unknown indication |
| 103402112 | 10340211 | 10 | Product used for unknown indication |
| 103402112 | 10340211 | 11 | Product used for unknown indication |
| 103402112 | 10340211 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103402112 | 10340211 | HO |
| 103402112 | 10340211 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103402112 | 10340211 | Acute kidney injury | |
| 103402112 | 10340211 | Epistaxis | |
| 103402112 | 10340211 | Gingival bleeding | |
| 103402112 | 10340211 | Haematuria | |
| 103402112 | 10340211 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |